back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-01 10:51 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,615
+140 vol $11.54 each |
13,133 | |
| Filed 2025-10-01 10:50 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-281 vol |
12,993 | |
| Filed 2025-07-03 03:35 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,652
+140 vol $11.80 each |
13,274 | |
| Filed 2025-07-03 03:34 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+280 vol |
13,134 | |
| Filed 2025-04-01 09:22 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,549
+139 vol $11.15 each |
12,854 | |
| Filed 2025-04-01 09:21 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+279 vol |
12,715 | |
| Filed 2025-03-19 09:40 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+420 vol |
12,436 | |
| Filed 2025-03-13 12:54 Tx date 2025-01-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$689.92
+77 vol $8.96 each |
12,016 | |
| Filed 2025-03-13 12:53 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,768
+185 vol $9.56 each |
11,939 | |
| Filed 2025-01-02 13:20 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,760
+160 vol $11.00 each |
11,754 | |
| Filed 2025-01-02 13:19 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+321 vol |
11,594 | |
| Filed 2024-10-03 14:46 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,713
+160 vol $10.71 each |
11,273 | |
| Filed 2024-10-03 14:45 Tx date 2024-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+320 vol |
11,113 | |
| Filed 2024-07-04 11:29 Tx date 2024-07-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,590
+159 vol $10.00 each |
10,793 | |
| Filed 2024-07-04 11:28 Tx date 2024-07-02 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+319 vol |
10,634 | |
| Filed 2024-04-02 09:56 Tx date 2024-04-01 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,373
+158 vol $8.69 each |
10,315 | |
| Filed 2024-04-02 09:55 Tx date 2024-04-01 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+317 vol |
10,157 | |
| Filed 2024-03-30 09:00 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,293 vol |
9,840 | |
| Filed 2024-03-24 10:00 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$770.28
+98 vol $7.86 each |
7,680 | |
| Filed 2024-03-24 09:59 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,616
+211 vol $7.66 each |
7,582 |